CAS 140405-36-3

Formel: C17H20N4O2

InChl: InChI=1S/C17H20N4O2/c1-3-21(4-2)15-6-5-14(16(22)11-15)12-19-20-17(23)13-7-9-18-10-8-13/h5-12,22H,3-4H2,1-2H3,(H,20,23)/b19-12+

InChI Key: GWQPCBPAOAFXSJ-XDHOZWIPSA-N

SMILES: CCN(CC)C1=CC(=C(C=C1)/C=N/NC(=O)C2=CC=NC=C2)O

RSVA405

CAS: 140405-36-3

RSVA405

Formel: C₁₇H₂₀N₄O₂

Reinheit: ≥98%

Molekulargewicht: 312.37

Ref: 54-BUP10843

Rsva 405

CAS: 140405-36-3

Formel: C₁₇H₂₀N₄O₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 312.3663

Ref: IN-DA01ENMK

RSVA405

CAS: 140405-36-3

RSVA405 is an AMPK activator (EC50 = 1 μM), and is STAT3 inhibitor

Formel: C₁₇H₂₀N₄O₂

Reinheit: 99.30%

Farbe und Form: Solid

Molekulargewicht: 312.3663

Ref: TM-T8476

RSVA 405

CAS: 140405-36-3

RSVA 405 is a drug that is used to reduce the risk of myopathy and other damage in patients who are undergoing surgery or other procedures. RSVA 405 is a non-ionic, non-thrombogenic, low viscosity, low protein binding, and non-inflammatory contrast agent. It can be administered intravenously or intraoperatively. RSVA 405 may be used as an alternative to ethyl palmitate because it has less potential for adverse effects on the heart. RSVA 405 has been shown to reduce infarct size in animal models by reducing reperfusion injury during the period of ischemia and reperfusion.

Formel: C₁₇H₂₀N₄O₂

Reinheit: Min. 95%

Molekulargewicht: 312.37 g/mol

Ref: 3D-QFA40536